CDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals.
Michigan Medical Spa Adds XERF™ as Skin Tightening Demand Rises Bingham Farms, United States - July 1, 2026 / FACE ...
Sartorius and LFB Biomanufacturing expand their CDMO partnership, integrating engineered CHO cell lines with GMP manufacturing capabilities.
Hims & Hers Health (HIMS) stock, Replimune (REPL) stock, and Capricor (CAPR) stock are in focus as the FDA brings back Advisory Committee meetings. Read more here.
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
Secures Global Framework for Composition-of-Matter and Method-of-Treatment Claims Covering Lead Program Ebstrocel for Epidermolysis Bullosa and ...
Despite fears of an innovation slowdown, stoked by funding cuts and FDA personnel shakeups, the agency approved 17 ...
A Medicare pilot beginning Wednesday will broaden access to medications like Wegovy and Zepbound. There are unique risks for those over 65.
Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or ...
Pierre-Alain Ruffieux of Cytiva discusses key biotech trends including new modalities, AI adoption, supply chain stability, ...
The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale ...
The agency expects to issue decisions on Vyondys 53 and Amondys 45, which missed their primary endpoint in a confirmatory trial, by February 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results